Why is Welcure Drugs falling/rising?

As of 12-Sep, Welcure Drugs & Pharmaceuticals Ltd is currently priced at 8.83, reflecting a decline of 0.46 or 4.95%. The stock has been underperforming, having lost 14.11% over the last three days and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 88.55% compared to the 5-day average. The stock's performance over the past week shows a decline of 9.99%, and it has experienced a year-to-date decrease of 24.34%, indicating ongoing challenges for the company.
In the broader market context, the Sensex has gained 1.48% over the past week, contrasting sharply with Welcure Drugs' negative performance. This underperformance is further highlighted by the stock's year-to-date decline compared to the Sensex's positive return of 4.82%. The significant disparity between the stock's returns and the benchmark suggests that investor sentiment towards Welcure Drugs is weak, contributing to its falling price amidst a generally stable market environment.